Author Question: To minimize the potential for kidney damage associated with giving acyclovir intravenously, the ... (Read 60 times)

abc · **on:** Jul 23, 2018

To minimize the potential for kidney damage associated with giving acyclovir intravenously, the nurse will:

1. decrease the client's protein intake two days before and two days after treatment.
2. hydrate the client intravenously during and for 2 hours after the infusion.
3. discontinue the infusion if there is any concern about a potential increase in levels of BUN.
4. limit oral fluids during infusion.

Question 2

The nurse is aware that to achieve the most therapeutic effects, the best time to administer oseltamivir (Tamiflu) or zanamivir (Relenza) is:

1. as soon as the client has been exposed to someone with influenza.
2. any time during the course of the illness.
3. at the same time as the vaccine.
4. within 48 hours of the onset of symptoms.

jsm54321 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

Correct Answer: 2
Rationale 1: When given IV, acyclovir is associated with nephrotoxicity, but decreasing protein intake will not decrease the potential for kidney damage.
Rationale 2: When given IV, acyclovir is associated with nephrotoxicity, so ensuring that the infusion is administered slowly and that the client is properly hydrated can lessen the potential for IV toxicity.
Rationale 3: Monitoring BUN levels is important, but another intervention is more crucial to decreasing the risk of kidney damage.
Rationale 4: When given IV, acyclovir is associated with nephrotoxicity. Oral fluids should not be limited.
Global Rationale: When given IV, acyclovir is associated with nephrotoxicity, so ensuring that the infusion is administered slowly and that the client is properly hydrated can lessen the potential for IV toxicity. Decreasing protein will have no effect. Monitoring BUN levels is important but will not prevent damage. Oral fluids should not be limited.

Answer to Question 2

Correct Answer: 4
Rationale 1: Oseltamivir (Tamiflu) and zanamivir (Relenza) should be given within 48 hours of the onset of symptoms.
Rationale 2: When oseltamivir and zanamivir are given within 48 hours of the onset of symptoms, their use can shorten the normal 7-day course of influenza to 5 days.
Rationale 3: Oseltamivir (Tamiflu) and zanamivir (Relenza) should be given within 48 hours of the onset of symptoms, not at the same time as the vaccine.
Rationale 4: Oseltamivir (Tamiflu) and zanamivir (Relenza) are examples of a new classification of drugs called neuraminidase inhibitors that are used to treat active influenza infection. When given within 48 hours of the onset of symptoms, their use can shorten the normal 7-day course of influenza to 5 days.
Global Rationale: Given within 48 hours of the onset of symptoms, the two neuraminidase inhibitors, oseltamivir (Tamiflu) and zanamivir (Relenza), will shorten the normal 7-day duration of influenza symptoms to 5 days.